// App-Quantinova.ai

2009 : Predicting isocitrate dehydrogenase genotype in malignant glioma with multimodality imaging markers.

Researchers

Presenter

  • Biqi Zhang

Principal Investigators

  • Ken Chang

  • Shakti Ramkissoon

  • Shyam Kumar Tanguturi

  • Wenya Linda Bi

  • David A. Reardon

  • Keith L. Ligon

  • Brian Michael Alexander

  • Patrick Y. Wen

  • Raymond Yi-kun Huang

Medical Centers

  • Harvard Medical School, Boston, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Harvard Radiation Oncology Program, Bayport, NY

  • Dana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber Cancer Institute/ Brigham and Women's Cancer Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gliomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved